Clinical Trials List
2006-12-01 - 2008-12-31
Phase III
Terminated9
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 鄭之勛 Division of General Internal Medicine
- Ping-Hung Kuo Division of General Internal Medicine
- 郭律成 Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- 吳惠東 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Reury-Perng Perng Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃建達 Division of Thoracic Medicine
- Horng-Chyuan Lin Division of Thoracic Medicine
- Chun-Liang Chou Division of Thoracic Medicine
- Shu-Min Lin Division of Thoracic Medicine
- Wen-Te Liu Division of Thoracic Medicine
- Han-Pin Kuo Division of Thoracic Medicine
- Chien-Ying Liu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王程遠 Division of General Internal Medicine
- Jen-Yu Hung Division of General Internal Medicine
- Chih-Jen Yang Division of General Internal Medicine
- 王東衡 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming -Cheng Chan Division of Thoracic Medicine
- 覃俊士 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 梁信杰 Division of Thoracic Medicine
- Te-Chun Hsia Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
200 participants
-
Global
0 participants
